Farglitazar

Farglitazar
Clinical data
Pregnancy
category
  • N/A
ATC code none
Legal status
Legal status
  • Investigational
Identifiers
CAS Number 196808-45-4 N
PubChem (CID) 170364
IUPHAR/BPS 2672
ChemSpider 148961 N
UNII 3433GY7132 YesY
ChEMBL CHEMBL107367 N
Chemical and physical data
Formula C34H30N2O5
Molar mass 546.612 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Farglitazar is a peroxisome proliferator-activated receptor agonist which is being developed by GlaxoSmithKline for the treatment of hepatic fibrosis. It is currently in phase II clinical trials.

References



    This article is issued from Wikipedia - version of the 8/22/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.